Reconstitution of active recombinant Shiga toxin (Stx)1 from recombinant Stx1-A and Stx1-B subunits independently produced by E. coli clones

FEMS Microbiology Letters

Volumn 178, Issue 1, 1999, Pages 13-18

  Nishikawa, Toru ^a   Fujii, Jun ^b   Yoshida, Shin Ichi ^c   Yutsudo, Takashi ^a  

^a SHIONOGI AND CO LTD   (Japan)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

In vitro protein synthesis; Reconstitution of recombinant toxin; Shiga toxin; Shiga like toxin; Vero toxin

Indexed keywords

SHIGA TOXIN;

ARTICLE; CLONE; CONTROLLED STUDY; CYTOTOXICITY; ESCHERICHIA COLI; GENE EXPRESSION SYSTEM; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; SUPERNATANT; VERO CELL;

ANIMALS; BACTERIAL PROTEINS; BACTERIAL TOXINS; CERCOPITHECUS AETHIOPS; CLONING, MOLECULAR; CYTOTOXINS; DIALYSIS; ESCHERICHIA COLI; GENE DELETION; GENES, BACTERIAL; POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS; SHIGA TOXINS; VERO CELLS;

ESCHERICHIA COLI;

EID: 0032812824     PISSN: 03781097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1097(99)00329-8     Document Type: Article

References (19)

1. Riley, L.W., Remis, R.S., Helgerson, S.D., McGee, H.B., Wells, J.G., Davis, B.R., Hebert, R.J., Olcott, E.S., Johnson, L.M., Hargrett, N.T., Blake, P.A. and Cohen, M.L. (1983) Hemorrhagic colitis associated with a rare Escherichia coli serotype. N. Engl. J. Med. 308, 681-685.
2. Paton, J.C. and Paton, A.W. (1998) Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections. Clin. Microbiol. Rev. 11, 450-479.
3. Griffin, P.M. (1995) Escherichia coli O157:H7 and other enterohemorrhagic Escherichia coli. In: Infections of the Gastrointestinal Tract (Blaser, M.J., Smith, P.D., Ravdin, J.I., Greenberg, H.B. and Guerran, R.L., Eds.), pp. 739-761. Raven Press, New York.
4. Siegler, R.L. (1994) Spectrum of extrarenal involvement in postdiarrheal hemolytic-uremic syndrome. J. Pediatr. 125, 511-518.
5. Kim, S.H., Cha, I.H., Kim, K.S., Kim, Y.H. and Lee, Y.C. (1997) Cloning and sequence analysis of another Shiga-like toxin IIe variant gene (slt-IIerd) from an Escherichia coli R107 strain isolated from rabbit. Microbiol. Immunol. 41, 805-808.
6. Takao, T., Tanabe, T., Hong, Y.M., Shimonishi, Y., Kurazono, H., Yutsudo, T., Sasakawa, C., Yoshikawa, M. and Takeda, Y. (1988) Identity of molecular structure of Shiga-like toxin I (VT1) from Escherichia coli O157:H7 with that of Shiga toxin. Microb. Pathog. 5, 57-69.
7. Yutsudo, T., Nakabayashi, N., Hirayama, T. and Takeda, Y. (1987) Purification and some properties of a Vero toxin from Escherichia coli O157:H7 that is immunologically unrelated to Shiga toxin. Microb. Pathog. 3, 21-30.
8. Ogasawara, T., Ito, K., Igarashi, K., Yutsudo, T., Nakabayashi, N. and Takeda, Y. (1988) Inhibition of protein synthesis by a Vero toxin (VT2 or Shiga-like toxin II) produced by Escherichia coli O157:H7 at the level of elongation factor 1-dependent aminoacyl-tRNA binding to ribosomes. Microb. Pathog. 4, 127-135.
9. Endo, Y., Tsurugi, K., Yutsudo, T., Takeda, Y., Ogasawara, T. and Igarashi, K. (1988) Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. Eur. J. Biochem. 171, 45-50.
10. Yoh, M., Frimpong, E.K. and Honda, T. (1997) Effect of antimicrobial agents, especially fosfomycin, on the production and release of Vero toxin by enterohemorrhagic Escherichia coli O157:H7. FEMS Immunol. Med. Microbiol. 19, 57-64.
11. Takeda, T., Yoshino, K., Uchida, H., Ikeda, N. and Tanimura, M. (1998) Early use of fosfomycin for Shiga toxin-producing Escherichia coli O157 infection reduces the risk of hemolytic-uremic syndrome. In: Escherichia coli O157:H7 and other Shiga toxin-producing E. coli strains (Kaper, J.B. and O'Brien, A.D., Eds.), pp. 385-387. American Society for Microbiology, Washington, DC.
12. Fujii, J., Kinoshita, Y., Yamada, Y., Yutsudo, T., Kita, T., Takeda, T. and Yoshida, S. (1998) Neurotoxicity of intrathecal Shigatoxin 2 and protection by intrathecal injection of anti-Shigatoxin 2 antiserum in rabbits. Microb. Pathog. 25, 139-146.
13. Bielaszewska, M., Clarke, I., Karmali, M.A. and Petric, M. (1997) Localization of intravenously administered verocytotoxins (Shiga-like toxins) 1 and 2 in rabbits immunized with homologous and heterologous toxoids and toxin subunits. Infect. Immun. 65, 2509-2516.
14. Zollman, T.M., Austin, P.R., Jablonski, P.E. and Hovde, C.J. (1994) Purification of recombinant Shiga-like toxin type 1 A1 fragment from Escherichia coli. Protein Expr. Purif. 5, 291-295.
15. Kurazono, H., Sasakawa, C., Yoshikawa, M. and Takeda, Y. (1987) Cloning of a Vero toxin (VT1, Shiga-like toxin I) gene from a VT1-converting phage isolated from Escherichia coli O157:H7. FEMS Microbiol. Lett. 44, 23-26.
16. Noda, M., Yutsudo, T., Nakabayashi, N., Hirayama, T. and Takeda, Y. (1987) Purification and some properties of Shiga-like toxin from Escherichia coli 0157:H7 that is immunologically identical to Shiga toxin. Microb. Pathog. 2, 339-349.
17. Ito, H., Yutsudo, T., Hirayama, T. and Takeda, Y. (1988) Isolation and some properties of A and B subunits of Vero toxin 2 and in vitro formation of hybrid toxins between subunits of Vero toxin 1 and Vero toxin 2 from Escherichia coli 0157:H7. Microb. Pathog. 5, 189-195.
18. Cossart, P., Boquet, P., Normark, S. and Rappuoli, R. (1996) Cellular microbiology emerging. Science 271, 315-316.
19. Lingwood, C.A. (1996) Role of verotoxin receptors in pathogenesis. Trends Microbiol. 4, 147-153.